73 related articles for article (PubMed ID: 7690802)
1. Isolation of erythrocyte membrane inhibitor of reactive lysis type II. Identification as glycophorin A.
Tomita A; Radike EL; Parker CJ
J Immunol; 1993 Sep; 151(6):3308-23. PubMed ID: 7690802
[TBL] [Abstract][Full Text] [Related]
2. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
3. Isolation of homologous restriction factor from human urine. Immunochemical properties and biologic activity.
Zalman LS; Brothers MA; Müller-Eberhard HJ
J Immunol; 1989 Sep; 143(6):1943-7. PubMed ID: 2476489
[TBL] [Abstract][Full Text] [Related]
4. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
Tomlinson S; Whitlow MB; Nussenzweig V
J Immunol; 1994 Feb; 152(4):1927-34. PubMed ID: 7509832
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum.
Wilcox LA; Ezzell JL; Bernshaw NJ; Parker CJ
Blood; 1991 Aug; 78(3):820-9. PubMed ID: 1713516
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells.
Hakulinen J; Meri S
Lab Invest; 1994 Dec; 71(6):820-7. PubMed ID: 7528832
[TBL] [Abstract][Full Text] [Related]
7. Paroxysmal nocturnal hemoglobinuria. Enhanced stimulation of platelets by the terminal complement components is related to the lack of C8bp in the membrane.
Blaas P; Berger B; Weber S; Peter HH; Hänsch GM
J Immunol; 1988 May; 140(9):3045-51. PubMed ID: 3361126
[TBL] [Abstract][Full Text] [Related]
8. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
[TBL] [Abstract][Full Text] [Related]
9. Shedding and enrichment of the glycolipid-anchored complement lysis inhibitor protectin (CD59) into milk fat globules.
Hakulinen J; Meri S
Immunology; 1995 Jul; 85(3):495-501. PubMed ID: 7558140
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement.
Hughes TR; Piddlesden SJ; Williams JD; Harrison RA; Morgan BP
Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):169-76. PubMed ID: 1376109
[TBL] [Abstract][Full Text] [Related]
11. A rapid method for the isolation of analogues of human CD59 by preparative SDS-PAGE: application to pig CD59.
van den Berg CW; Harrison RA; Morgan BP
J Immunol Methods; 1995 Feb; 179(2):223-31. PubMed ID: 7533195
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.
Holguin MH; Fredrick LR; Bernshaw NJ; Wilcox LA; Parker CJ
J Clin Invest; 1989 Jul; 84(1):7-17. PubMed ID: 2738160
[TBL] [Abstract][Full Text] [Related]
13. Erythrocyte membrane inhibitor of reactive lysis: effects of phosphatidylinositol-specific phospholipase C on the isolated and cell-associated protein.
Holguin MH; Wilcox LA; Bernshaw NJ; Rosse WF; Parker CJ
Blood; 1990 Jan; 75(1):284-9. PubMed ID: 1688497
[TBL] [Abstract][Full Text] [Related]
14. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
[TBL] [Abstract][Full Text] [Related]
15. The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity.
van den Berg CW; Harrison RA; Morgan BP
Immunology; 1993 Mar; 78(3):349-57. PubMed ID: 7682985
[TBL] [Abstract][Full Text] [Related]
16. Physiologic relevance of the membrane attack complex inhibitory protein CD59 in human seminal plasma: CD59 is present on extracellular organelles (prostasomes), binds cell membranes, and inhibits complement-mediated lysis.
Rooney IA; Atkinson JP; Krul ES; Schonfeld G; Polakoski K; Saffitz JE; Morgan BP
J Exp Med; 1993 May; 177(5):1409-20. PubMed ID: 7683035
[TBL] [Abstract][Full Text] [Related]
17. Glycophorin A inhibits lysis by the complement attack phase.
Brauch H; Roelcke D; Rother U
Immunobiology; 1983 Aug; 165(2):115-20. PubMed ID: 6629410
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
[TBL] [Abstract][Full Text] [Related]
19. Deficiency of phosphatidylinositol-linked membrane proteins on erythrocytes of different subpopulations in paroxysmal nocturnal hemoglobinuria.
Cui Y; Zhang ZN; Liu EK; Pan HZ
Chin Med J (Engl); 1993 May; 106(5):323-30. PubMed ID: 7691484
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
